Revolution Medicines Intangible Assets

Revolution Medicines (RVMD) currently reports a intangible assets of $56M as of March 2026. That compares with $56M in the prior-year period — down 1.1% year over year. Use the charts on this page to explore Revolution Medicines's intangible assets history and peer comparisons.

Revolution Medicines's intangible assets decreased from $56M to $56M — a 1.1% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Revolution Medicines reported $56M in intangible assets as of March 2026. That compares with $56M in the prior-year period — down 1.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $56M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Revolution Medicines, and consider following RVMD for alerts when major investors trade the stock.

Revolution Medicines is classified in the Healthcare sector. On intangible assets, it currently shows $56M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RVMD with unrelated industries.